<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Is it worth conducting clinical trials of modern drugs and devices in the European Union? Is the EU attractive for investment compared to other parts of the world?	</title>
	<atom:link href="https://www.kg-legal.eu/info/pharmaceutical-healthcare-life-sciences-law/is-it-worth-conducting-clinical-trials-of-modern-drugs-and-devices-in-the-european-union-is-the-eu-attractive-for-investment-compared-to-other-parts-of-the-world/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.kg-legal.eu/info/pharmaceutical-healthcare-life-sciences-law/is-it-worth-conducting-clinical-trials-of-modern-drugs-and-devices-in-the-european-union-is-the-eu-attractive-for-investment-compared-to-other-parts-of-the-world/</link>
	<description>KIELTYKA GLADKOWSKI LEGAL &#124; CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</description>
	<lastBuildDate>Tue, 14 May 2024 12:46:51 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
</channel>
</rss>
